One new 19-nor cucurbitane-type triterpenoid from the stems of Momordica charantia

References

• Akihisa T, Higo N, Tokuda H, Ukiya M, Akazawa H, Tochigi Y, Kimura Y, Suzuki T, Nishino H. 2007. Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. J Nat Prod. 70:1233–1239.10.1021/np068075p
   PubMed Web of Science ®Google Scholar
• Bao B, Chen YG, Zhang L, Na Xu YL, Wang X, Liu J, Qu W. 2013. Momordica charantia (bitter melon) reduces obesity-associated macrophage and mast cell infiltration as well as inflammatory cytokine expression in adipose tissues. PloS One 8:e84075.10.1371/journal.pone.0084075
   PubMed Web of Science ®Google Scholar
• Battelli MG, Polito L, Bolognesi A, Lafleur L, Fradet Y, Stirpe F. 1996. Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line. Int J Cancer. 65:485–490.10.1002/(ISSN)1097-0215
   PubMed Web of Science ®Google Scholar
• Chen JC, Liu WQ, Lu L, Qiu MH, Zheng YT, Yang LM, Zhang XM, Zhou L, Li ZR. 2009. Kuguacins F–S, cucurbitane triterpenoids from Momordica charantia. Phytochemistry 70:133–140.10.1016/j.phytochem.2008.10.011
   PubMed Web of Science ®Google Scholar
• Cheng BH, Chen JC, Liu JQ, Zhou L, Qiu MH. 2013. Cucurbitane-type triterpenoids from Momordica charantia. Helv Chim Acta. 96:1111–1120.10.1002/hlca.v96.6
   Web of Science ®Google Scholar
• El-Gengaihi S, Karawya MS, Selim MA, Motawe HM, Ibrahim N, Faddah LM. 1995. A novel pyrimidine glycoside from Momordica charantia L. Pharmazie. 50:361–362.
   Web of Science ®Google Scholar
• Erharuyi O, Engel-Lutz N, Ahomafor J, Imieje V, Falodun A, Nebe B, Langer P. 2014. Anticancer activity of five forest crops used in African folklore: antiproliferative and pro-apoptotic effects. Nat Prod Res. 28:740–745. doi:10.1080/14786419.2013.879475
   Google Scholar
• Fatope MO, Takeda Y, Yamashita H, Okabe H, Yamauchi T. 1990. New cucurbitane triterpenoids from Momordica charantia. J Nat Prod. 53:1491–1497.10.1021/np50072a014
   Web of Science ®Google Scholar
• Harinantenaina L, Tanaka M, Takaoka S, Oda M, Mogami O, Uchida M, Asakawa Y. 2006. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull. 54:1017–1021.10.1248/cpb.54.1017
   PubMed Web of Science ®Google Scholar
• Keller AC, Ma J, Kavalier A, He K, Brillantes AB, Kennelly EJ. 2011. Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro. Phytomedicine 19:32–37.10.1016/j.phymed.2011.06.019
   PubMed Web of Science ®Google Scholar
• Lin KW, Yang SC, Lin CN. 2011. Antioxidant constituents from the stems and fruits of Momordica charantia. Food Chem. 127:609–614.10.1016/j.foodchem.2011.01.051
   PubMed Web of Science ®Google Scholar
• Liu JQ, Chen JC, Wang CF, Qiu MH. 2010. New cucurbitane triterpenoids and steroidal glycoside from Momordica charantia. Molecules 1:4804–4813.
   Google Scholar
• Liu CH, Yen MH, Tsang SF, Gan KH, Hsu HY, Lin CN. 2010. Antioxidant triterpenoids from the stems of Momordica charantia. Food Chem. 118:751–756.10.1016/j.foodchem.2009.05.058
   Web of Science ®Google Scholar
• Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63.10.1016/0022-1759(83)90303-4
   PubMed Web of Science ®Google Scholar
• Mulholland DA, Sewram V, Osborne R, Pegel KH, Connolly JD. 1997. Cucurbitane triterpenoids from the leaves of Momordica foetida. Phytochemistry 45:391–395.10.1016/S0031-9422(96)00814-X
   Web of Science ®Google Scholar
• Murakami T, Emoto A, Matsuda H, Yoshikawa M. 2001. Medicinal foodstuffs. xxi. structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem Pharm Bull 49:54–63.10.1248/cpb.49.54
   PubMed Web of Science ®Google Scholar
• Pitchakarn P, Ogawa K, Suzuki S, Takahashi S, Asamoto M, Chewonarin T, Limtrakul P, Shirai T. 2010. Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo. Cancer Sci. 101:2234–2240.10.1111/cas.2010.101.issue-10
   PubMed Web of Science ®Google Scholar
• Pitchakarn P, Suzuki S, Ogawa K, Pompimon W, Takahashi S, Asamoto M, Limtrakul P, Shirai T. 2011. Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf. Cancer Lett. 306:142–150.10.1016/j.canlet.2011.02.041
   PubMed Web of Science ®Google Scholar
• Popovich DG, Lee Y, Li L, Zhang W. 2011. Momordica charantia seed extract reduces pre-adipocyte viability, affects lactate dehydrogenase release, and lipid accumulation in 3T3-L1 cells. J Med Food. 14:201–208.10.1089/jmf.2010.1150
   PubMed Web of Science ®Google Scholar
• Ray RB, Raychoudhuri A, Steele R, Nerurkar P. 2010. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res. 70:1925–1931.10.1158/0008-5472.CAN-09-3438
   PubMed Web of Science ®Google Scholar
• Tan MJ, Ye JM, Turner N, Hohnen-Behrens C, Ke CQ, Tang CP, Chen T, Weiss HC, Gesing ER, Rowland A, James DE, Ye Y. 2008. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol. 15:263–273.10.1016/j.chembiol.2008.01.013
   PubMed Web of Science ®Google Scholar
• Yaldız G, Sekeroglu N, Kulak M, Demirkol G. 2015. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation. Nat Prod Res. 29: 543–545.10.1080/14786419.2014.949706
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang Y, Kikuchi T, Tokuda H, Suzuki N, Inafuku KI, Miura M, Motohashi S, Suzuki T, Akihisa T. 2012. Cucurbitane triterpenoids from the leaves of Momordica charantia, and their cancer chemopreventive effects and cytotoxicities. Chem Biodivers. 9:428–440.10.1002/cbdv.v9.2
   PubMed Web of Science ®Google Scholar